Joseph Truitt, EVP, Chief Commercial Officer at ACHILLION PHARMACEUTICALS INC (ACHN), sold 25,000 shares at $7.82 ($196K) on 2014-06-16, disclosed to the SEC on 2014-06-17.
Scheduled sale ($196k) by EVP, Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACHN | BUY | 2016-12-05 | $14K | — | Filing → |
| ACHN | SELL | 2014-08-26 | $271K | — | Filing → |
| ACHN | SELL | 2014-06-11 | $301K | — | Filing → |